Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Interferon-gamma MeSH Descriptor Data 2025


MeSH Heading
Interferon-gamma
Tree Number(s)
D12.644.276.374.440.893
D12.644.276.374.480.615.350
D12.776.467.374.440.893
D12.776.467.374.480.615.350
D23.529.374.440.893
D23.529.374.480.615.350
Unique ID
D007371
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D007371
Scope Note
The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES.
Entry Term(s)
Interferon Type II
Interferon, Immune
Interferon, gamma
Type II Interferon
gamma-Interferon
Pharm Action
Antiviral Agents
Registry Numbers
82115-62-6
CAS Type 1 Name
Interferon gamma (human lymphocyte protein moiety reduced)
Previous Indexing
Interferons (1966-1982)
See Also
Interferon-gamma Release Tests
Public MeSH Note
2009; see INTERFERON TYPE II 1984-2008, see INTERFERON, GAMMA 1983-1990
History Note
2009(1983); INTERFERON-GAMMA was INTERFERON, GAMMA 1983-1990
Date Established
1983/01/01
Date of Entry
1982/05/19
Revision Date
2015/06/22
Interferon-gamma Preferred
page delivered in 0.131s